Published in TB and Outbreaks Week, October 2nd, 1995
The study found that improved management of the widely used anti-tuberculosis agent in this group of patients may allow its continued use, even in countries with widespread HIV infection.
Thiacetazone, one of the semicarbazones, has become an important weapon in tuberculosis control throughout developing countries because it is inexpensive, efficacious and widely available.
During the past few years, however, serious cutaneous reactions to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.